Langzeitverlauf bei 60 Patienten mit alveolärer Echinokokkose unter Dauertherapie mit Mebendazol (1976–85)
Authors:
- M. ZieglerMZM. Ziegler
- 1 November 1988
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 66 (21) , 1060-1073
Abstract
Since 1976 60 patients with inoperable alveolar echinococcosis caused by Echinococcus multilocularis were treated with high doses of mebendazole and examined at regular intervals prospectively according to our protocol regarding clinical course, liver function, morphology, immunologically and plasma mebendazole levels. The average duration of disease was 8(1–19) years, the average duration of chemotherapy was 4.25 (0.75–9) years. The long term results showed a correlation of the clinical course with the mean plasma mebendazole levels and the duration of chemotherapy, respectively. Death (n=5) or transient progression of the disease process (n=14) was observed primarily in patients with low plasma mebendazole levels in the early course and within the first two years of chemotherapy. Only 9 patients showed a decrease of the parasite mass. Immundiagnosis (total serum IgE and serum antibodies against Echinococcus antigen) gave some information with regard to therapy results, but only in the long-term course. The cumulative survival of the patients under study was 96% at 5 years and 84% at 10 years, respectively which is markedly higher compared to historical control series with a letality of >90% within 10 years.Keywords
This publication has 17 references indexed in Scilit:
- [New findings on echinococcosis].1986
- Treatment of hydatid disease with high oral doses of mebendazoleEuropean Journal of Clinical Pharmacology, 1986
- High oral doses of mebendazole interfere with growth of larval Echinococcus multilocularis lesionsJournal of Hepatology, 1985
- Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazoleParasitology Research, 1984
- [Diagnosis and therapy of echinococcosis].1983
- Human echinococcosis: Follow-up of 23 patients treated with mebendazoleInfection, 1983
- Mebendazole and alveolar hydatid diseasePathogens and Global Health, 1982
- Essai de traitement de l'échinococcose alvéolaire par le flubendazole. A propos de 7 observationsMedecine Et Maladies Infectieuses, 1982
- Chemotherapy for larval echinococcosis in animals and humans: Report of a workshopParasitology Research, 1982
- Chemotherapy of alveolar echinococcosisEuropean Journal of Clinical Pharmacology, 1981